QT8-14016-59826
1 vaccination
1 coded response
12 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 836 / ID
- Registered
- 2022-09-29
- Relationship
- Child or adolescent in my care
- Guardian
- 26K-30730-29422
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-29
Registered in v-safe
-
2022-09-29
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-29
Health check-in — day 0, dose 1, dependentFeeling: Poor · Fever · Chills, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-09-30
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Redness · NauseaAdult check-in
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-12-29
-
2023-03-30
Survey response — 6 months, dose 1, dependentMedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-29 | Pfizer-BioNTech | Flu |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release